BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 35995341)

  • 21. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
    Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
    Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
    Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
    J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting STAT proteins via computational analysis in colorectal cancer.
    Dariya B; Muppala S; Srivani G; Momin S; Alam A; Saddala MS
    Mol Cell Biochem; 2021 Jan; 476(1):165-174. PubMed ID: 32840738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
    Haura EB; Turkson J; Jove R
    Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic distribution of signal transducer and activator of transcription (STAT) family in colorectal cancer.
    Hu Y; Shen Y; Zhao Y; Tang Y; Liu C; Gu Y; Yang T; Shen Y
    Hum Cell; 2023 Jan; 36(1):286-295. PubMed ID: 36284066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
    Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
    Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.
    Lai SY; Johnson FM
    Drug Resist Updat; 2010 Jun; 13(3):67-78. PubMed ID: 20471303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
    Liu C; Xing H; Guo C; Yang Z; Wang Y; Wang Y
    Cell Cycle; 2019 Sep; 18(18):2215-2227. PubMed ID: 31286834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study.
    Slattery ML; Lundgreen A; Hines LM; Torres-Mejia G; Wolff RK; Stern MC; John EM
    Breast Cancer Res Treat; 2014 Aug; 147(1):145-58. PubMed ID: 25104439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
    Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
    Front Genet; 2023; 14():1120500. PubMed ID: 36968603
    [No Abstract]   [Full Text] [Related]  

  • 34. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells.
    Dumler I; Kopmann A; Wagner K; Mayboroda OA; Jerke U; Dietz R; Haller H; Gulba DC
    J Biol Chem; 1999 Aug; 274(34):24059-65. PubMed ID: 10446176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.
    Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB
    J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling pathways governing breast cancer stem cells behavior.
    Song K; Farzaneh M
    Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling.
    Segatto I; Berton S; Sonego M; Massarut S; Perin T; Piccoli E; Colombatti A; Vecchione A; Baldassarre G; Belletti B
    Oncotarget; 2014 Aug; 5(15):6267-79. PubMed ID: 25026286
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.